Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Raihana, Diallo-Danebrock"'
Autor:
Ronald E. Kates, Manfred Schmitt, Karin Mengele, O Gluz, Raihana Diallo-Danebrock, Nadia Harbeck, Frauke Neff, Svjetlana Mohrmann, E. Ting, Christopher Poremba, Marion Kiechle, Niels Eckstein, Hans-Dieter Royer, Ulrike Nitz
Publikováno v:
Journal of Clinical Oncology. 27:6144-6151
PurposeTo investigate the potential of Y-box–binding protein YB-1, a multifunctional protein linked to tumor aggressiveness and multidrug resistance, to identify patients with breast cancer likely to benefit from dose-intensified chemotherapy regim
Autor:
Christopher Poremba, Edgar Dahl, Arndt Hartmann, Svjetlana Mohrmann, Robert Meiler, Oleg Gluz, Peter J. Wild, Andreas Gaumann, Alexander Herr, Gerhart Schuett, Markus Frick, E. Ting, Ulrike Nitz, Thomas J. Fuchs, Raihana Diallo-Danebrock
Publikováno v:
International Journal of Cancer. 123:1433-1438
Intensive lymph node involvement indicates poor prognosis in breast cancer patients. The significance of other molecular prognostic factors in this subgroup is unclear. Karyopherin alpha2 (KPNA2) has been reported as an important factor of tumorgenes
Autor:
Philip C, Schouten, Oleg, Gluz, Nadia, Harbeck, Svjetlana, Mohrmann, Raihana, Diallo-Danebrock, Enrico, Pelz, Janneke, Kruizinga, Arno, Velds, Marja, Nieuwland, Ron M, Kerkhoven, Cornelia, Liedtke, Markus, Frick, Ronald, Kates, Sabine C, Linn, Ulrike, Nitz, Frederik, Marme
Publikováno v:
International journal of cancer. 139(4)
BRCA1 is an important protein in the repair of DNA double strand breaks (DSBs), which are induced by alkylating chemotherapy. A BRCA1-like DNA copy number signature derived from tumors with a BRCA1 mutation is indicative for impaired BRCA1 function a
Publikováno v:
Acta radiologica (Stockholm, Sweden : 1987). 52(3)
Background Intraductal papillomas often present as small, smooth masses, dilated ducts or microcalcifications at mammography and as smooth, hypoechoic masses at sonography. At magnetic resonance imaging (MRI), intraductal papillomas often present as
Autor:
Mario Colombo-Benkmann, Norbert Senninger, Karl-Ludwig Schaefer, Thomas M. Mundel, Karl-Heinz Dietl, Raihana Diallo-Danebrock
Publikováno v:
Cancer biologytherapy. 6(11)
Renal cell carcinoma (RCC) occurring in renal allografts after cadaveric kidney transplantation has rarely been observed. RCC accounts for 2.3% of all malignancies in the general population, but up to 4.8% of malignancies in renal transplant recipien
Autor:
Raihana Diallo-Danebrock, G. Schütt, Alexander Herr, O Gluz, Walter Lindemann, U. Nitz, S Mohrmann, Christopher Poremba, Christian Jackisch, E. Ting
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 3
Publikováno v:
BMC Cancer
BMC Cancer, Vol 6, Iss 1, p 157 (2006)
BMC Cancer, Vol 6, Iss 1, p 157 (2006)
Background It is widely accepted that vulvar carcinoma with a depth of invasion of less than one millimeter is sufficiently treated by vulvectomy or wide local excision without inguinal lymphadenectomy. Case presentation However, a patient with ingui
Autor:
Svjetlana Mohrmann, Ron M. Kerkhoven, Philip C. Schouten, Raihana Diallo-Danebrock, E Pelz, Frederik Marmé, Nadia Harbeck, Oleg Gluz, Ronald E. Kates, Janneke Kruizinga, Cornelia Liedtke, Marja Nieuwland, Ulrike Nitz, Arno Velds, Markus Frick, Sabine C. Linn
Publikováno v:
Journal of Clinical Oncology. 32:11018-11018
11018 Background: DNA copy number profiles identify patients with a defect in BRCA1 associated with a homologous recombination DNA repair defect. We previously showed that patients with a BRCA1-lik...
Autor:
Hans-Dieter Royer, Raihana Diallo-Danebrock, Svjetlana Mohrmann, O Gluz, E. Ting, Nadia Harbeck, Michael Schmitt, M. Kiechle-Bahat, Karin Mengele, U. Nitz, Ronald E. Kates
Publikováno v:
Journal of Clinical Oncology. 25:563-563
563 Background: Y-box binding protein (YB-1), known as oncogenic transcription factor, is associated with up-regulation of MDR1, alters p53 function, and induces growth of an aggressive phenotype. In high-risk breast cancer, the prospective randomize
Autor:
M. Frick, Raihana Diallo-Danebrock, Alexander Herr, Christopher Poremba, E. Ting, Walter Lindemann, Christian Jackisch, O Gluz, U. Nitz, Svjetlana Mohrmann
Publikováno v:
Journal of Clinical Oncology. 24:665-665
665 Background: The WSG AM 01 trial is the first one to report superiority of HDC in terms of DFS and OS in patients with >9 positive axillary lymph nodes. Retrospectively we tried to identify patient subgroups with maximum benefit from HDC. Methods: